Halyard Health Inc (HYH) Releases Earnings Results, Beats Expectations By $0.09 EPS

Halyard Health Inc (HYH) reported quarterly earnings results on Wednesday, Aug-3-2016. The company said it had a profit of $0.45 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.09. Analysts had a consensus of $0.36. The company posted revenue of $400.00 million in the period, compared to analysts expectations of $382.39 million. The company’s revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.52 EPS.

Many Wall Street Analysts have commented on Halyard Health Inc. Company shares were Reiterated by Stifel on Jun 14, 2016 to “Buy”, Firm has raised the Price Target to $ 37 from a previous price target of $32 .

Halyard Health Inc closed down -0.23 points or -0.68% at $33.84 with 4,80,919 shares getting traded on Tusday. Post opening the session at $34.17, the shares hit an intraday low of $33.54 and an intraday high of $34.47 and the price fluctuated in this range throughout the day.Shares ended Tusday session in Red.

In a different news, on Sep 8, 2015, Robert E Abernathy (CEO) purchased 10,000 shares at $31.06 per share price. According to the SEC, on Sep 2, 2015, Steven E Voskuil (CFO) purchased 1,000 shares at $30.00 per share price.

Halyard Health Inc. seeks to advance health and healthcare by preventing infection eliminating pain and speeding recovery. The Company has two business segments: Surgical and Infection Prevention (S&IP) and Medical Devices. The Company’s S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. S&IP’s product portfolio includes sterilization wrap surgical drapes and gowns facial protection protective apparel and medical exam gloves. Medical Devices segment provides a portfolio of product offerings including post-operative pain management solutions minimally invasive interventional (or chronic) pain therapies closed airway suction systems and enteral feeding tubes focused on pain management and respiratory and digestive health.

Halyard Health Inc

Leave a Reply

Halyard Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Halyard Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.